{
"info": {
"nct_id": "NCT01495676",
"official_title": "A Randomized Phase II Trial Evaluating an Organ-conserving Strategy With Radiotherapy + CDDP + Gemcitabine vs Radiotherapy + CDDP in Muscle-infiltrative Bladder Cancer",
"inclusion_criteria": "* Muscle invasive urothelial cancer (front line or following the progression of a superficial tumor), pT2-pT3 stage without lymphatic impairment (N0) and without detectable metastases (M0). An optimal macroscopic resection (TURB) have to be performed\n* The proof of invasive tumor to the muscle should be brought by a transurethral resection under anaesthesia less than 8 weeks before or, in the absence, by superficial biopsies and formal imaging. Multiples biopsies in the bladder must also be performed.\n* Age ≥ 18 years\n* Life expectancy ≥ 6 months\n* Kanorfsky index ≥ 70 % (WHO 0, 1, 2)\n* Biological criteria: neutrophils ≥ 1500/mm3, Platelets ≥ 100 000/mm3, haemoglobin ≥ 10 g/dl, creatinine clearance > 60 ml/mn\n* No distant metastases (Thorax, abdomen, and pelvic CT-scan, bone scan)\n* Efficient contraception for premenopausal women, maintained during the whole treatment and up to two months after the completion of radiotherapy.\n* No radiotherapy or chemotherapy history except for in situ bladder lesions.\n* No carcinological history except for non melanoma skin tumours, in situ uterine cervix cancer\n* No contraindication to gemcitabine or cisplatin.\n* No contraindication to radiotherapy\n* Information letter and informed consent signed\n* Patient covered by social security\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Bladder tumors without any muscle infiltration\n* Epidermoid carcinoma or adenocarcinoma\n* Distance metastases or extrapelvic node positivity\n* Severe digestive history (ulcerative colitis, complicated diverticulitis)\n* Pregnancy and breast feeding",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Muscle invasive urothelial cancer (front line or following the progression of a superficial tumor), pT2-pT3 stage without lymphatic impairment (N0) and without detectable metastases (M0). An optimal macroscopic resection (TURB) have to be performed",
"criterions": [
{
"exact_snippets": "Muscle invasive urothelial cancer",
"criterion": "urothelial cancer",
"requirements": [
{
"requirement_type": "invasiveness",
"expected_value": "muscle invasive"
}
]
},
{
"exact_snippets": "pT2-pT3 stage",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"pT2",
"pT3"
]
}
]
},
{
"exact_snippets": "without lymphatic impairment (N0)",
"criterion": "lymphatic impairment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "without detectable metastases (M0)",
"criterion": "metastases",
"requirements": [
{
"requirement_type": "detectability",
"expected_value": false
}
]
},
{
"exact_snippets": "An optimal macroscopic resection (TURB) have to be performed",
"criterion": "macroscopic resection (TURB)",
"requirements": [
{
"requirement_type": "performance",
"expected_value": true
}
]
}
]
},
{
"line": "* The proof of invasive tumor to the muscle should be brought by a transurethral resection under anaesthesia less than 8 weeks before or, in the absence, by superficial biopsies and formal imaging. Multiples biopsies in the bladder must also be performed.",
"criterions": [
{
"exact_snippets": "proof of invasive tumor to the muscle",
"criterion": "invasive tumor to the muscle",
"requirements": [
{
"requirement_type": "proof",
"expected_value": true
}
]
},
{
"exact_snippets": "transurethral resection under anaesthesia less than 8 weeks before",
"criterion": "transurethral resection under anaesthesia",
"requirements": [
{
"requirement_type": "time since procedure",
"expected_value": {
"operator": "<",
"value": 8,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "superficial biopsies",
"criterion": "superficial biopsies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "formal imaging",
"criterion": "formal imaging",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Multiples biopsies in the bladder must also be performed",
"criterion": "multiple biopsies in the bladder",
"requirements": [
{
"requirement_type": "performance",
"expected_value": true
}
]
}
]
},
{
"line": "* Age ≥ 18 years",
"criterions": [
{
"exact_snippets": "Age ≥ 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Life expectancy ≥ 6 months",
"criterions": [
{
"exact_snippets": "Life expectancy ≥ 6 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Kanorfsky index ≥ 70 % (WHO 0, 1, 2)",
"criterions": [
{
"exact_snippets": "Kanorfsky index ≥ 70 %",
"criterion": "Kanorfsky index",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
]
},
{
"exact_snippets": "WHO 0, 1, 2",
"criterion": "WHO performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
}
]
},
{
"line": "* Biological criteria: neutrophils ≥ 1500/mm3, Platelets ≥ 100 000/mm3, haemoglobin ≥ 10 g/dl, creatinine clearance > 60 ml/mn",
"criterions": [
{
"exact_snippets": "neutrophils ≥ 1500/mm3",
"criterion": "neutrophils",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Platelets ≥ 100 000/mm3",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "haemoglobin ≥ 10 g/dl",
"criterion": "haemoglobin",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "g/dl"
}
}
]
},
{
"exact_snippets": "creatinine clearance > 60 ml/mn",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 60,
"unit": "ml/mn"
}
}
]
}
]
},
{
"line": "* No distant metastases (Thorax, abdomen, and pelvic CT-scan, bone scan)",
"criterions": [
{
"exact_snippets": "No distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Thorax, abdomen, and pelvic CT-scan",
"criterion": "CT-scan",
"requirements": [
{
"requirement_type": "regions",
"expected_value": [
"thorax",
"abdomen",
"pelvic"
]
}
]
},
{
"exact_snippets": "bone scan",
"criterion": "bone scan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Efficient contraception for premenopausal women, maintained during the whole treatment and up to two months after the completion of radiotherapy.",
"criterions": [
{
"exact_snippets": "Efficient contraception for premenopausal women",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "efficiency",
"expected_value": true
}
]
},
{
"exact_snippets": "premenopausal women",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "premenopausal"
}
]
},
{
"exact_snippets": "maintained during the whole treatment and up to two months after the completion of radiotherapy",
"criterion": "contraception duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during the whole treatment and up to two months after the completion of radiotherapy"
}
]
}
]
},
{
"line": "* No radiotherapy or chemotherapy history except for in situ bladder lesions.",
"criterions": [
{
"exact_snippets": "No radiotherapy ... history",
"criterion": "radiotherapy history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... chemotherapy history",
"criterion": "chemotherapy history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except for in situ bladder lesions",
"criterion": "in situ bladder lesions",
"requirements": [
{
"requirement_type": "exception",
"expected_value": true
}
]
}
]
},
{
"line": "* No carcinological history except for non melanoma skin tumours, in situ uterine cervix cancer",
"criterions": [
{
"exact_snippets": "No carcinological history",
"criterion": "carcinological history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except for non melanoma skin tumours",
"criterion": "non melanoma skin tumours",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "except for ... in situ uterine cervix cancer",
"criterion": "in situ uterine cervix cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No contraindication to gemcitabine or cisplatin.",
"criterions": [
{
"exact_snippets": "No contraindication to gemcitabine",
"criterion": "contraindication to gemcitabine",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No contraindication to ... cisplatin",
"criterion": "contraindication to cisplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No contraindication to radiotherapy",
"criterions": [
{
"exact_snippets": "No contraindication to radiotherapy",
"criterion": "contraindication to radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Information letter and informed consent signed",
"criterions": [
{
"exact_snippets": "Information letter and informed consent signed",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient covered by social security",
"criterions": [
{
"exact_snippets": "Patient covered by social security",
"criterion": "social security coverage",
"requirements": [
{
"requirement_type": "coverage",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Bladder tumors without any muscle infiltration",
"criterions": [
{
"exact_snippets": "Bladder tumors",
"criterion": "bladder tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "without any muscle infiltration",
"criterion": "muscle infiltration",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Epidermoid carcinoma or adenocarcinoma",
"criterions": [
{
"exact_snippets": "Epidermoid carcinoma",
"criterion": "epidermoid carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "adenocarcinoma",
"criterion": "adenocarcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Distance metastases or extrapelvic node positivity",
"criterions": [
{
"exact_snippets": "Distance metastases",
"criterion": "distance metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "extrapelvic node positivity",
"criterion": "extrapelvic node positivity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Severe digestive history (ulcerative colitis, complicated diverticulitis)",
"criterions": [
{
"exact_snippets": "Severe digestive history (ulcerative colitis, complicated diverticulitis)",
"criterion": "digestive history",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "conditions",
"expected_value": [
"ulcerative colitis",
"complicated diverticulitis"
]
}
]
}
]
},
{
"line": "* Pregnancy and breast feeding",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breast feeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}